SeQuent Scientific Ltd
NSE:SEQUENT

Watchlist Manager
SeQuent Scientific Ltd Logo
SeQuent Scientific Ltd
NSE:SEQUENT
Watchlist
Price: 203.85 INR -1.6% Market Closed
Market Cap: ₹51.5B

Net Margin

1.9%
Current
Improving
by 5.2%
vs 3-y average of -3.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1.9%
=
Net Income
₹296.8m
/
Revenue
₹16B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1.9%
=
Net Income
₹296.8m
/
Revenue
₹16B

Peer Comparison

Country Company Market Cap Net
Margin
IN
SeQuent Scientific Ltd
NSE:SEQUENT
51B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.8B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Lower than 72% of companies in India
Percentile
28th
Based on 5 531 companies
28th percentile
1.9%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

SeQuent Scientific Ltd
Glance View

Market Cap
51.5B INR
Industry
Pharmaceuticals

SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.

SEQUENT Intrinsic Value
106.3 INR
Overvaluation 48%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
1.9%
=
Net Income
₹296.8m
/
Revenue
₹16B
What is SeQuent Scientific Ltd's current Net Margin?

The current Net Margin for SeQuent Scientific Ltd is 1.9%, which is above its 3-year median of -3.3%.

How has Net Margin changed over time?

Over the last 3 years, SeQuent Scientific Ltd’s Net Margin has increased from 1.8% to 1.9%. During this period, it reached a low of -10.3% on Sep 30, 2023 and a high of 1.9% on Jun 30, 2025.

Back to Top